2m 2m 2m 2m 2m 2m 2m
Vertex Pharma (VRTX)
NASDAQ
$470.12+$3.32 (+0.71%)
Price as of Jun 23, 2026 2:13 PM EDT- $118.5BMarket Cap
- 5.24%1-Year Change
- BiotechnologyIndustry
Vertex Pharma (VRTX)
$470.12+$3.32 (+0.71%)
VRTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $466.79 | ||
Change | +$15.16 (+3.36%) | ||
Open | $455.65 | ||
High | $468.18 | ||
Low | $453.21 | ||
Previous Close | $451.63 | ||
Volume | 2,034,574 | ||
30-Day Average Volume | 1,411,275 | ||
1-Week Change | 3.63% | ||
1-Month Change | 7.43% | ||
1-Year Change | 5.24% | ||
3-Year Change | 34.07% | ||
5-Year Change | 147.15% | ||
Fundamentals | |||
Shares Outstanding | 253.8M | ||
Total Assets | $26.5B | ||
Market Cap | $118.5B | ||
Enterprise Value | $113.0B | ||
Period: QTR TTM FY | |||
Revenue | $3.0B | ||
Net Income | $1.0B | ||
Free Cash Flow | $1.3B | ||
EBIT | $1.3B | ||
EBITDA | $1.3B | ||
Net Working Capital | $7.8B | ||
EPS | $4.02 | ||
Enterprise Value/EBITDA | 86 | ||
Enterprise Value/Revenue | 38 | ||
P/B | 6 | ||
P/E | 116 | ||
PEG | -9 | ||
Price/Free Cash Flow | 92 | ||
Price/Operating Cash Flow | 83 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue